Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

The Seattle-based biotech company aims to make new drug discovery faster and cheaper by using AI to simulate the results from ...

The era of digital twins offers a future where deep biology, AI and real-world data combine to make medicine more personal, ...